BioVantage Global

 

BioVantage Global Limited (“BVG”) is a biotechnology licensing platform originating from Malaysia, focused on developing, patenting, and globally licensing science-backed, 100% natural health formulations. The Company’s portfolio comprises eight proprietary core products targeting key areas of preventive healthcare, including cardiovascular, cognitive, metabolic, immune, digestive, musculoskeletal, and overall wellness.

​

BVG operates an asset-light, licensing-driven model, manufacturing its products in US FDA-certified facilities and licensing its patented formulations to partners worldwide. The Company is transitioning from a local operating structure to a unified global brand, with governance, quality, and reporting standards aligned with US and EU public-market expectations.

​

BVG’s mission is to deliver accessible, science-backed natural healthcare solutions that support long-term health and vitality, with the vision of becoming a globally recognized preventive healthcare platform.

​

​

 

BioVantage Global’s operating philosophy is focused on preventive, science-backed natural healthcare, with an emphasis on product integrity, intellectual property protection, and compliance with international quality standards.
 

The Company operates an asset-light, IP-driven business model, developing and patenting proprietary natural health formulations that are manufactured in US FDA-certified facilities and monetized primarily through global licensing and brand partnerships.
 

BVG’s growth strategy centers on international expansion through licensing, unifying products under the BioVantage Global brand, strengthening patent protection for its eight core products, and upgrading governance and reporting to US and EU public-market standards. The Company’s objective is to build a scalable global natural healthcare platform with sustainable, long-term growth.

​